⌘K

Login Start Free

Home/Filings/4/0001415889-25-023557

4//SEC Filing

Moat Ross 4

Accession 0001415889-25-023557

CIK 0001730430other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:49 PM ET

Size

26.1 KB

Accession

0001415889-25-023557

Insider Transaction Report

Form 4

Period: 2025-09-01

Kiniksa Pharmaceuticals International, plcKNSA

CHIEF COMMERCIAL OFFICER

Transactions

Exercise/Conversion
Class A Ordinary Share
2025-09-01+2,477→ 15,244 total
Tax Payment
Class A Ordinary Share
2025-09-01$33.49/sh−2,819$94,408→ 12,425 total
Exercise/Conversion
Restricted Share Unit
2025-09-02−994→ 0 total
→ Class A Ordinary Share (994 underlying)
Exercise/Conversion
Class A Ordinary Share
2025-09-02+994→ 13,419 total
Exercise/Conversion
Class A Ordinary Share
2025-09-01+1,741→ 11,156 total
Exercise/Conversion
Class A Ordinary Share
2025-09-01+1,611→ 12,767 total
Award
Share Option
2025-09-01+39,364→ 39,364 total
Exercise: $33.49Exp: 2035-08-31→ Class A Ordinary Share (39,364 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-01−1,741→ 5,221 total
→ Class A Ordinary Share (1,741 underlying)
Tax Payment
Class A Ordinary Share
2025-09-02$34.28/sh−481$16,489→ 12,938 total
Award
Restricted Share Unit
2025-09-01+9,828→ 9,828 total
→ Class A Ordinary Share (9,828 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-01−1,611→ 3,222 total
→ Class A Ordinary Share (1,611 underlying)
Exercise/Conversion
Restricted Share Unit
2025-09-01−2,477→ 2,477 total
→ Class A Ordinary Share (2,477 underlying)

Footnotes (7)

[F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
[F2]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2025.
[F3]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025.
[F4]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
[F5]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
[F6]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
[F7]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.

Documents

1 file

4
form4-09032025_080909.xmlPrimary

Issuer

Kiniksa Pharmaceuticals International, plc

CIK 0001730430

Entity typeother

Related Parties

1

filerCIK 0001857177

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 4:49 PM ET
Size: 26.1 KB

View on SEC.gov